BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4193300)

  • 21. [Some methods in clinical distinction and treatment of lymphogranulomatosis of the stomach].
    Zdichynec B
    Vnitr Lek; 1974 Sep; 20(9):932-3. PubMed ID: 4410914
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of chronic diseases of connective tissue by cytostatic drugs].
    Deicher H; Fricke R; Kruli P
    Rev Clin Esp; 1970 Mar; 116(6):539-48. PubMed ID: 4996836
    [No Abstract]   [Full Text] [Related]  

  • 23. [Radiation and combined treatment of stage 3 and 4 lymphogranulomatosis patients].
    Baĭsogolov GD; Khmelevskaia ZI; Nogtikova LT
    Vopr Onkol; 1970; 16(2):19-26. PubMed ID: 5439776
    [No Abstract]   [Full Text] [Related]  

  • 24. Hodgkin's disease of the spleen: some clinical aspects and problems.
    Storti E; Casirola G; Marini G; Ippoliti G; Ascari E; Ferrari E
    Haematologia (Budap); 1974; 8(1-4):493-505. PubMed ID: 4461434
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cytostatic immunosuppressive therapy, chromosomal aberrations and carcinogenic effect (author's transl)].
    Vormittag W
    Wien Klin Wochenschr; 1974 Feb; 86(3):69-75. PubMed ID: 4439938
    [No Abstract]   [Full Text] [Related]  

  • 26. Fatal strongyloidiasis in Hodgkin's disease after immunosuppressive therapy.
    Yim Y; Kikkawa Y; Tanowitz H; Wittner M
    J Trop Med Hyg; 1970 Oct; 73(10):245-9. PubMed ID: 5312266
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy of the lymphomas.
    Todd ID
    Proc R Soc Med; 1970 Jan; 63(1):86-8. PubMed ID: 5417792
    [No Abstract]   [Full Text] [Related]  

  • 28. Morphologic effects of cytotoxic drugs on tumor cells.
    Beumer HM; Porton WM
    Dis Chest; 1968 Mar; 53(3):252-6. PubMed ID: 5640893
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic trial in disseminated Hodgkin's disease (stages 3 and IV) by sequence chemotherapy, radiotherapy, eventually associated with splenectomy and supplementary chemotherapy].
    Amiel JL; Schlienger M; Laugier A; Rouëssé J; Jasmin C; Hayat M; Tubiana M; Mathé G
    Nouv Rev Fr Hematol; 1970; 10(5):597-608. PubMed ID: 4250282
    [No Abstract]   [Full Text] [Related]  

  • 30. [Recurrences in lymphogranulomatosis].
    Kovalenko NS; Fokina NT
    Ter Arkh; 1983; 55(8):43-8. PubMed ID: 6688890
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy of advanced lymphomas.
    Kurnick JE; Robinson WA
    Arch Intern Med; 1972 Jun; 129(6):908-13. PubMed ID: 5067727
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract]   [Full Text] [Related]  

  • 33. [Secondary tumors in hemoblastoses during cytostatic treatment].
    Hartwich G; Butzler W
    Med Klin; 1971 Oct; 66(43):1445-50. PubMed ID: 5001553
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of lymphogranulomatosis].
    Baĭsogolov GD; Khmelevskaia ZI
    Klin Med (Mosk); 1972 Jan; 50(1):34-40. PubMed ID: 5020027
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of lymphatic systemic diseases (lymphogranulomatosis, lympho- and reticulum cell sarcoma)].
    Brunner KW
    Verh Dtsch Ges Inn Med; 1973; 79():168-84. PubMed ID: 4597610
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal changes following treatment with cytostatic drugs (Trenimon, cyclophosphamide, Imuran). Light and electron microscopic studies on the rat kidney].
    Tessmann D; Schill H; Voss J; Hamann H; Engelmann C
    Zentralbl Allg Pathol; 1972; 115(5):522-31. PubMed ID: 4627720
    [No Abstract]   [Full Text] [Related]  

  • 37. [Liver function in lymphogranulomatosis].
    Sarnitskiĭ IP; Temnik IV
    Vopr Onkol; 1979; 25(6):12-5. PubMed ID: 462863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
    Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A
    J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Causes for failures in the treatment of localized forms of lymphogranulomatosis].
    Pakulina LE; Chekharina EA
    Vopr Onkol; 1973 May; 19(5):36-41. PubMed ID: 4714734
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vinblastine in the treatment of Hodgkin's disease].
    Hansen I; Nissen NI
    Nord Med; 1971 Dec; 86(50):1526-30. PubMed ID: 5135058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.